Genetics and Genomics for the Prevention and Treatment of Cardiovascular Disease: Update
- Most cardiovascular disease (CVD) is complex, with genetic, environmental, and epigenetic factors influencing disease progression.
- The rapid progression of genomic technologies has greatly expanded our knowledge of CVDs and stroke over the last several years.
- Continued research and education are necessary to facilitate the translation of genomic discoveries to clinical practice.
Supporting Materials
Recommended
- Genome-Wide Analysis of Blood Pressure Variability and Ischemic Stroke (opens in a new window)(link opens in new window)
- Genetic Architecture of Carotid Artery Intima-Media Thickness in Mexican Americans (opens in a new window)(link opens in new window)
- “Good Enough Solutions” and the Genetics of Complex Diseases (opens in a new window)(link opens in new window)
- Genetics and Cardiovascular Disease: A Policy Statement From the American Heart Association (opens in a new window)(link opens in new window)
- Relevance of Genetics and Genomics for Prevention and Treatment of Cardiovascular Disease (opens in a new window)(link opens in new window)&